Marie Buchholz
4PUBLICATIONS
7CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Aug 10, 2024
Differential miRNA and Protein Expression Reveals miR-1285, Its Targets TGM2 and CDH-1, as Well as CD166 and S100A13 as Potential New Biomarkers in Patients with Diabetes Mellitus and Pancreatic Adenocarcinoma.Theodoros Kolokotronis, Britta Majchrzak-Stiller, Marie Buchholz
|Jul 27, 2024
Maintenance Therapy for Pancreatic Cancer, a New Approach Based on the Synergy between the Novel Agent GP-2250 (Misetionamide) and Gemcitabine.Marie Buchholz, Britta Majchrzak-Stiller, Ilka Peters
|Jul 09, 2022
Substance GP-2250 as a New Therapeutic Agent for Malignant Peritoneal Mesothelioma-A 3-D In Vitro Study.Claudia Baron, Marie Buchholz, Britta Majchrzak-Stiller
|Jun 10, 2022
New Therapy Options for Neuroendocrine Carcinoma of the Pancreas-The Emergent Substance GP-2250 and Gemcitabine Prove to Be Highly Effective without the Development of Secondary Resistances In Vitro and In Vivo.Marie Buchholz, Johanna Strotmann, Britta Majchrzak-Stiller
Pageof 1
